𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Platelet mitochondrial respiratory chain function in Parkinson's disease

✍ Scribed by C. I. Blake; E. Spitz; M. Leehey; Dr. B. J. Hoffer; S. J. Boyson


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
644 KB
Volume
12
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Reports on mitochondrial respiratory chain (MRC) complex I (CI) dysfunction in the substantia nigra in Parkinson's disease (PD) support the oxidative stress hypothesis in the neuropathogenesis of PD. Studies in peripheral tissue have found variable decreased CI and occasionally other complex activity suggestive of systemic impairment of MRC function in PD; however, MRC activity may be influenced by numerous variables. We conducted spectrophotometric measurements of MRC function in platelet mitochondrial preparations in 13 individuals with PD and 9 age‐matched controls (CON) and have identified additional variables that may affect MRC activity. Mean CI, CIII, CIV, and citrate synthase (CS) activities were similar between PD and CON. CIII and CIV, specific and CS‐corrected, activities were significantly positively correlated with CI in combined and individual group data, with the exception of CIII CS‐corrected and CIV specific activities in CON and PD, respectively. CIII and CS specific activities were negatively correlated with age in CON, but varied randomly in PD. In PD, CIII specific activity was 1.4‐fold higher in those with a history of environmental risk factors for PD and CIV specific activity was lower in those with a positive family history of PD [8.34 Β± 0.74 (n = 4) vs. 12.4 Β± 1.1 (SEM) min^βˆ’1^ mg^βˆ’1^; p = 0.046]. Group heterogeneity, variables affecting enzyme activity, and intrinsic properties of cells may thus contribute to conflicting data in studies of MRC function in platelets and other tissues.


πŸ“œ SIMILAR VOLUMES


Mitochondrial function in Parkinson's di
✍ Fiorenzo Dagani; Jeffrey J. Anderson; Thomas N. Chase πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 2 views
Mitochondrial function in Parkinson's di
✍ Prof. Anthony H. V. Schapira; Vincent M. Mann; J. Mark Cooper; David Krige; Pete πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 1000 KB
Effect of aging and dopaminomimetic ther
✍ Daniele Bravi; Jeffrey J. Anderson; Fiorenzo Dagani; Thomas L. Davis; Rosaria Fe πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 380 KB

## Abstract Oxygen consumption and enzyme activity were evaluted in platelet mitochondria from 17 patients with Parkinson's disease. In comparison with age‐matched controls, no consistent abnormality could be discerned in complex I, complex II‐III, or complex IV oxygen consumption, or in the enzyme

Mitochondrial respiratory chain function
✍ M. Gu; M. T. Gash; J. M. Cooper; G. K. Wenning; S. E. Daniel; N. P. Quinn; C. D. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 412 KB

## Abstract Multiple system atrophy (MSA) is a clinicopathological entity distinct from idiopathic Parkinson's disease (PD) that is responsible for 5–10% of cases of parkinsonism. Degeneration of nigral neurones is a feature of both diseases. A specific deficiency of mitochondrial complex I activit

Mitochondrial abnormalities in Parkinson
✍ Yoshikuni Mizuno; Shin-Ichirou Ikebe; Nobutaka Hattori; Yuko Nakagawa-Hattori; M πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 1 views